Showing results (1121-1130 of 3,860) with videos related to

Sort By:
Pageof 386
Computational and Structural Biotechnology Journal|March 23, 2022
Development of a dynamic network biomarkers method and its application for detecting the tipping point of prior disease developmentChongyin Han, Jiayuan Zhong, Qinqin Zhang, et al.
Computational and Structural Biotechnology Journal|March 23, 2022
MPEPE, a predictive approach to improve protein expression in E. coli based on deep learningZundan Ding, Feifei Guan, Guoshun Xu, et al.
Computational and Structural Biotechnology Journal|March 31, 2022
Deep learning in prediction of intrinsic disorder in proteinsBi Zhao, Lukasz Kurgan
Computational and Structural Biotechnology Journal|April 7, 2022
Network-based stage-specific drug repurposing for Alzheimer's diseaseKyriaki Savva, Margarita Zachariou, Marilena M Bourdakou, et al.
Computational and Structural Biotechnology Journal|October 20, 2021
Structure-guided machine learning prediction of drug resistance mutations in Abelson 1 kinaseYunzhuo Zhou, Stephanie Portelli, Megan Pat, et al.
Computational and Structural Biotechnology Journal|February 28, 2022
Compounds targeting GPI biosynthesis or N-glycosylation are active against Plasmodium falciparumÀngel Fenollar, Albert Ros-Lucas, María Pía Alberione, et al.
Computational and Structural Biotechnology Journal|February 28, 2022
ADDAGMA: A database for domestic animal gut microbiome atlasYueren Xu, Bingbing Lei, Qingfeng Zhang, et al.
Computational and Structural Biotechnology Journal|February 24, 2022
Structural and biochemical characterization of the relaxosome auxiliary proteins encoded on the Bacillus subtilis plasmid pLS20Isidro Crespo, Nerea Bernardo, Anna Cuppari, et al.
Computational and Structural Biotechnology Journal|March 21, 2022
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compoundsIo Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova, et al.
Computational and Structural Biotechnology Journal|March 4, 2022
Identification of (Z)-2-benzylidene-dihydroimidazothiazolone derivatives as tyrosinase inhibitors: Anti-melanogenic effects and in silico studiesHeejeong Choi, Il Young Ryu, Inkyu Choi, et al.
Pageof 386